Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study on the Utility of Continuous Glucose Monitoring for the Diagnosis of Dumping Syndrome After Esophagectomy

NCT07605481 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07605481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07605481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study on the Utility of Continuous Glucose Monitoring for the Diagnosis of Dumping Syndrome After Esophagectomy
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
June 15, 2026
Completion date
December 31, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

continous glucose measurement, dumping syndrome, esophagectomy